Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing testis tumors during a period of time
go back to main search page
Accession:CMO:0001261 term browser browse the term
Definition:The number of new cases of individuals developing one or more testis tumors appearing in a study population during a certain period compared to the total number of individuals in the study population, expressed as a percentage.
Synonyms:related_synonym: testis tumor incidence


GViewer not supported for the selected species.

show annotations for term's descendants           Sort by:

Related Phenotype Data for Term "percentage of study population developing testis tumors during a period of time" (CMO:0001261)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 0
    tumor measurement 0
      tumor incidence/prevalence measurement 0
        testis tumor incidence/prevalence measurement 0
          percentage of study population developing testis tumors during a period of time 0
            percentage of study population developing bilateral testis tumors during a period of time 0
Path 2
Term Annotations click to browse term
  clinical measurement 0
    organ measurement 0
      organ lesion measurement 0
        organ tumorous lesion measurement 0
          testis tumorous lesion measurement 0
            testis tumor measurement 0
              testis tumor incidence/prevalence measurement 0
                percentage of study population developing testis tumors during a period of time 0
                  percentage of study population developing bilateral testis tumors during a period of time 0
paths to the root